Medical Imaging Screening for Posterior-circulation Ischemic Stroke

Status Recruiting

Clinical Trial Summary

Patients with ischemic stroke in the posterior circulation continue to have high rates of mortality and disability, even with aggressive treatment. We wanted to evaluate preoperative imaging to screen patients with a good prognosis from mechanical embolization. We assess the degree of ischemia by defining the pons-midbrain-medulla index (PMMI) and correlate the preoperative PMMI with the clinical prognosis of postoperative patients to verify the validity of PMMI in predicting the clinical prognosis of patients with embolization.

Clinical Trial Description

- The ENDOSTROKE registry (Endovascular Stroke T reatment Registry), the use of MRI before EVT was associated with significantly better clinical outcomes as compared to CT. - The purpose of the study will sift patients with posterior circulation ischemia stroke who will get better outcome by Mechanical Thrombectomy by neuroimaging.Specifically, the following assumption will be evaluated: the modified pons-midbrain index in magnetic resonance imaging can predict the clinical outcome of patients with basilar artery thrombosis 90 days after surgery, and can guide whether patients will undergo mechanical thrombectomy later. - Pons-midbrain-medulla index (PMMI) : We divide pons-midbrain-medulla into the left and right sides by the median line of the brainstem,so we will evaluate ischemia of these six layers which are endowed different score according to the degree of ischemia. Instead of the previous pons-midbrain index (PMI), we select the image layer that shows the largest infarct size among the six parts.Then,we add up six scores that is patient's PMMI. Scoring criteria: At the layer of displaying the maximum infarct size, 2 points are scored if the infarct size exceeds 50% of the total area, 1 point is scored if the infarct size is less than 50% of the total area, and 0 points are scored if there is no infarct.Finally, PMMI values range from 0 to 12 points. - The investigators conduct a multicenter, prospective cohort study.Preoperative images of patients are evaluated by different groups of imaging physicians to describe the association between preoperative PMMI and clinical prognosis in patients with posterior circulation stroke and to verify its validity. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06094569
Study type	Observational
Source	Tianjin Huanhu Hospital
Contact	Ming Wei, PhD
Phone	13502182903
Email	drweiming@163.com
Status	Recruiting
Phase
Start date	June 1, 2019
Completion date	December 31, 2029

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04484350` - Blood Pressure Management in Stroke Following Endovascular Treatment	Phase 2
Recruiting	`NCT04121611` - Optical Coherence Tomography Guided Antithrombotic Treatment After Endovascular Thrombectomy of the Posterior Circulation	N/A
Recruiting	`NCT04517383` - Effects of Post-Operative Sedation for Endovascular Thrombectomy	N/A
Enrolling by invitation	`NCT06361017` - The Prediction of Hemorrhage Transformation by Cerebral Autoregulation in AIS Patient After Endovascular Thrombectomy
Recruiting	`NCT05708079` - Multidimensional Evaluation of Patients With Acute Ischemic Stroke Undergoing Pharmacological and Endovascular Revascularization Procedures for the Identification of Positive Prognostic Factors
Completed	`NCT05684172` - Intra-arterial TNK Following Endovascular Thrombectomy in Patients With Large Vessel Occlusion of Posterior Circulation	Phase 2/Phase 3
Completed	`NCT04116112` - Blood Pressure After Endovascular Stroke Therapy-II	Phase 2
Completed	`NCT06290076` - A Predictive Model and Scoring System for Severe Complications After Endovascular Thrombectomy
Recruiting	`NCT05735301` - MR Imaging Selection for Endovascular Treatment in Acute Ischemic Stroke at 6 to 24 Hours	N/A
Recruiting	`NCT06200753` - Triage of Patients Presenting Beyond 24 Hours With Acute Ischemic Stroke Due to Large Vessel Occlusions (TRACK-LVO Late)
Completed	`NCT04667637` - Improving Neuroprotective Strategy for Ischemic Stroke With Sufficient Recanalization After Thrombectomy by Edaravone Dexborneol	Phase 2
Recruiting	`NCT06146790` - Evaluation of Endovascular Treatment in Acute Intracranial Distal Medium Vessel Occlusion Stroke	N/A
Completed	`NCT06213870` - Screening of Endovascular Thrombectomy With MRI in Acute Ischemic Stroke

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.